SGLT2 inhibitors × cardiac & vascular function

TrialCardiovascular diabetology2021

Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial.

Kenya Kusunose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

One number in the abstract

the abstract, start to end

level from baseline to 24 weeks was 0.98 (95% CI 0.89-1.08) in the

← favours treatmentfavours comparator →
could be chance
Cardiac & vascular function
0.980.89–1.08
SGLT2 inhibitorsCardiac & vascular function
1 / 3

13 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34521417